Table 1.
Cytotoxic and antiproliferative activities of the 2,5-DHBA–gelatin conjugate.
| Substance | Concentration, µg/mL | Cytotoxicity (%) (a) | Antiproliferative Activity (%) (a) | ||
|---|---|---|---|---|---|
| HT1080 | A-172 | HT1080 | A-172 | ||
| 2,5-DHBA–gelatin | 1000 | 104 ± 15 | 97 ± 12 | 102 ± 16 | 102 ± 13 | 
| 300 | 96 ± 12 | 96 ± 14 | 99 ± 14 | 101 ± 12 | |
| 100 | 103 ± 16 | 100 ± 13 | 104 ± 17 | 94 ± 17 | |
| 30 | 95 ± 13 | 93 ± 14 | 96 ± 17 | 96 ± 16 | |
| 10 | 97 ± 15 | 99 ± 16 | 93 ± 14 | 96 ± 15 | |
| Heparin | 1000 | 104 ± 17 | 97 ± 14 | 95 ± 15 | 92 ± 15 | 
| 300 | 101 ± 13 | 99 ± 14 | 94 ± 12 | 98 ± 14 | |
| 100 | 101 ± 12 | 105 ± 15 | 99 ± 13 | 98 ± 14 | |
| 30 | 93 ± 14 | 96 ± 15 | 103 ± 15 | 102 ± 16 | |
| 10 | 98 ± 13 | 94 ± 13 | 101 ± 15 | 95 ± 11 | |
| Chondroitin sulfate | 1000 | 100 ± 16 | 99 ± 12 | 91 ± 12 | 94 ± 16 | 
| 300 | 100 ± 12 | 103 ± 13 | 95 ± 14 | 92 ± 15 | |
| 100 | 104 ± 16 | 105 ± 13 | 93 ± 12 | 95 ± 15 | |
| 30 | 94 ± 14 | 101 ± 16 | 99 ± 12 | 100 ± 13 | |
| 10 | 99 ± 16 | 95 ± 16 | 100 ± 13 | 101 ± 13 | |
| Dermatan sulfate | 1000 | 99 ± 17 | 102 ± 15 | 92 ± 13 | 91 ± 15 | 
| 300 | 103 ± 14 | 97 ± 13 | 96 ± 14 | 93 ± 14 | |
| 100 | 104 ± 18 | 100 ± 14 | 101 ± 13 | 95 ± 14 | |
| 30 | 101 ± 16 | 101 ± 15 | 95 ± 14 | 104 ± 14 | |
| 10 | 97 ± 14 | 96 ± 14 | 103 ± 15 | 107 ± 17 | |
| Geldanamycin (b) | 5.6 | 5 ± 3 | 0 | 0 | 0 | 
| 0.56 | 43 ± 9 | 3 ± 3 | 13 ± 7 | 0 | |
| 0.056 | 94 ± 11 | 13 ± 4 | 55 ± 12 | 2 ± 2 | |
| 0.0056 | 98 ± 15 | 78 ± 14 | 100 ± 16 | 57 ± 8 | |
(a) The mean OD550 values for cells treated with different substances relative to control untreated cells, expressed as percentage, are presented. The mean OD550 value of control untreated cells was taken as 100%. The mean values of four to six repeats ± SD are presented. (b) Geldanamycin, which exhibits cytotoxic and antiproliferative activities, was used as a positive control.